EcoDrugPlus

Ribosomal Protein L35a

Ensembl ID : ENSNFUG00015003307
Gene Symbol: RPL35A
1 Cross references
452 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSNFUG00015003531
Gene Symbol: RPL37
3 Cross references
424 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSNFUG00015025332
Gene Symbol: RPL38
1 Cross references
198 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSNFUG00015000213
Gene Symbol: RPL39
1 Cross references
146 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSNFUG00015008298
Gene Symbol: RPL4
3 Cross references
341 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSNFUG00015019531
Gene Symbol: RPL5
3 Cross references
469 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSNFUG00015008108
Gene Symbol: RPL5
3 Cross references
404 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSNFUG00015015428
Gene Symbol: RPL6
3 Cross references
486 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSNFUG00015012915
Gene Symbol: RPL7
3 Cross references
492 Possible Orthologues:

Ribosomal Protein L7a

Ensembl ID : ENSNFUG00015007670
Gene Symbol: RPL7A
1 Cross references
370 Possible Orthologues:

Ribosomal Protein L8

Ensembl ID : ENSNFUG00015012104
Gene Symbol: RPL8
3 Cross references
276 Possible Orthologues:

Ribosomal Protein L9

Ensembl ID : ENSNFUG00015007955
Gene Symbol: RPL9
3 Cross references
509 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).